The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL
- PMID: 27133071
- DOI: 10.1016/j.biopha.2016.03.035
The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL
Abstract
MicroRNA-429 (miR-429) has been suggested to inhibit epithelial-mesenchymal transition (EMT), mainly due to targeting of ZEB1 and ZEB2, which are repressors of the cell to cell contact protein, E-cadherin. In this study, we indicated that regulation of miR-429 in cervical cancer cells modulates cell migration, elongation, as well as transforming growth factor β (TGF-β)-induced stress fiber formation through regulating the cytoskeleton reorganization which is likely independent of the zinc finger E-box binding homeobox (ZEB)/E-cadherin axis. ZEB1 and Crk-like adapter protein (CRKL), as novel targets of miR-429 and direct regulators of the actin cytoskeleton were identified. Remarkably, expression levels of ZEB1 and CRKL were inversely associated with the level of miR-429 in cervical cancer cell lines. In addition, individual knockdown and over-expression of these targeting genes phenocopied the roles of miR-429 over-expression and inhibition on cell elongation, migration, stress fiber formation, and invasion. Targeting of ZEB1 by miR-429 led to a decreased expression and transcriptional activity of CRB3, regulated by interference with the translocation of the CRB3. This finally led to decreasing of the expression of Crumbs 3 (CRB3), which is needed for the formation of stress fiber and contractility. Therefore, miR-429 affects cervical cancer by modulating some EMT-related processes. And in this study, evidences were provided to support a role for miR-429 as a novel target suppressing invasion and migration of human cervical cancer cells through modulation of its targeting genes ZEB1 and CRKL. Taken together, our data indicate that miR-429 plays a pivotal role in cervical cancer progression, which is a potential therapeutic target for patients.
Keywords: CRKL; Cervical cancer; Invasion; ZEB1; miR-429.
Copyright © 2016. Published by Elsevier Masson SAS.
Similar articles
-
The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.Sci Rep. 2016 Jan 5;6:18652. doi: 10.1038/srep18652. Sci Rep. 2016. PMID: 26728244 Free PMC article.
-
UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019. Theranostics. 2019. Retraction in: Theranostics. 2020 Jul 25;10(21):9619. doi: 10.7150/thno.50254. PMID: 31037155 Free PMC article. Retracted.
-
MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F.Mol Cell Biol. 2012 Feb;32(3):633-51. doi: 10.1128/MCB.06212-11. Epub 2011 Dec 5. Mol Cell Biol. 2012. PMID: 22144583 Free PMC article.
-
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.J Mol Med (Berl). 2016 Jun;94(6):629-44. doi: 10.1007/s00109-016-1420-5. Epub 2016 Apr 20. J Mol Med (Berl). 2016. PMID: 27094812 Review.
-
MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.Biomolecules. 2020 Jul 12;10(7):1040. doi: 10.3390/biom10071040. Biomolecules. 2020. PMID: 32664703 Free PMC article. Review.
Cited by
-
Down-regulation of microRNA-429 alleviates myocardial injury of rats with coronary heart disease.Cell Cycle. 2019 Oct;18(19):2550-2565. doi: 10.1080/15384101.2019.1652037. Epub 2019 Aug 23. Cell Cycle. 2019. Retraction in: Cell Cycle. 2022 Apr;21(7):765. doi: 10.1080/15384101.2022.2046807. PMID: 31438762 Free PMC article. Retracted.
-
Computational approaches for discovering significant microRNAs, microRNA-mRNA regulatory pathways, and therapeutic protein targets in endometrial cancer.Front Genet. 2023 Jan 10;13:1105173. doi: 10.3389/fgene.2022.1105173. eCollection 2022. Front Genet. 2023. PMID: 36704357 Free PMC article.
-
miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.Sci Rep. 2018 Feb 5;8(1):2375. doi: 10.1038/s41598-018-20258-8. Sci Rep. 2018. PMID: 29403024 Free PMC article.
-
The p130Cas-Crk/CrkL Axis: A Therapeutic Target for Invasive Cancers Unveiled by Collaboration Among p130Cas, Crk, and CrkL.Int J Mol Sci. 2025 Apr 24;26(9):4017. doi: 10.3390/ijms26094017. Int J Mol Sci. 2025. PMID: 40362257 Free PMC article. Review.
-
miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools.Biomed Eng Online. 2021 Feb 16;20(1):21. doi: 10.1186/s12938-021-00857-9. Biomed Eng Online. 2021. PMID: 33593374 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous